WA8242A1, A2 and B, novel secretory phospholipase A2 inhibitors produced by Streptomyces violaceusniger. I. Taxonomy, production and purification

Journal of Antibiotics

Volumn 51, Issue 1, 1998, Pages 1-7

  Yoshimura, Seiji ^a   Otsuka, Takanao ^a   Tsurumi, Yasuhisa ^a   Muramatsu, Yuko ^a   Hatanaka, Hiroshi ^a   Okamoto, Masanori ^a   Hashimoto, Seiji ^a   Okuhara, Masakuni ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOADIPIC ACID; ALKYL GROUP; PHOSPHOLIPASE A2 INHIBITOR; UNCLASSIFIED DRUG; WA 8242A1; WA 8242A2; WA 8242B; ADIPIC ACID DERIVATIVE; ENZYME INHIBITOR; PHOSPHOLIPASE A; WA8242A1; WA8242A2; WA8242B;

ARTICLE; BACTERIUM CULTURE; DRUG PURIFICATION; MYCELIUM; NONHUMAN; PRIORITY JOURNAL; STREPTOMYCES; STREPTOMYCES VIOLACEUSNIGER; TAXONOMY; CHEMISTRY; CLASSIFICATION; DRUG ANTAGONISM; ISOLATION AND PURIFICATION;

2-AMINOADIPIC ACID; ADIPIC ACIDS; ENZYME INHIBITORS; PHOSPHOLIPASES A; STREPTOMYCES;

EID: 0031612607     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.1     Document Type: Article

References (28)

1. 2. J. Biol. Chem. 269: 13057-13060, 1994
2. 2 in human sera and its clinical significance. J. Clin. Biochem. Nutr. 11: 91-100, 1991
3. 2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sci. 50: 807-811, 1992
4. 2 in pleural effusion of patients with tuberculosis. Life Sci. 49: 1095-1102, 1991
5. 2 as an index of desease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. J. Rheumatol. 23: 1162-1166, 1996
6. 2 and C in myocardial ischemic reperfusion injury. Am. J. Physiol. 260: H877-H833. 1991
7. 2. J. Immunol. 151: 5675-5684, 1993
8. 2 inhibitors produced by Streptomyces violaceusniger. II. Biological properties. J. Antibiotics 51: 8-13, 1998
9. 2 inhibitors produced by Streptomyces violaceusniger. III. Structure elucidation and total synthesis. J. Antibiotics, in preparation
10. SHIRLING, E. B. & D. GOTTLIEB: Methods for characterization of Streptomyces species. Int. J. Sys. Bacteriol. 16: 313-340, 1966
11. WAKSMAN, S. A.: Classification, identification and description of genera and species. The actinomycetes Vol. 2, The Williams and Willkins Co., Baltimore, 1961
12. KORNERUP, A. & J. H. WANSCHER: Methuen Handbook of Colour, Methuen, London, 1978
13. BECKER, B.: M. P. LECHEVALIER, R. E. GORDON & H. A. LECHEVALIER: Rapid differentiation between Nocardia and Streptomyces by paper chromatography of whole-cell hydrolysates. Appl. Micribiol. 12: 421-423, 1964
14. 2 with pyrene-labeled lecitin as a substrate. Anal. Biochem. 116: 553-558, 1981
15. BUCHANAN, R. E. & N. E. GIBBONS: BERGY'S Manual of Determinative Bacteriology. 8th ed., The Williams and Willkins Co., Baltimore, 1974
16. WILLIAMS, S. T.: BERGEY'S Manual of Systemic Bacteriology. Vol. 4, The Williams and Willkins Co., Baltimore, 1989
17. LABEDA, D. P. & A. J. LYONS: The Streptomyces violaceusniger cluster is heterogeneous in DNA relatedness of S. violacsusniger and S. hygroscopious. Int. J. Syst. Bacteriol. 41: 398-401, 1991
18. 2 by the marine natural products manoalide, luffariellolide and scalaradial. J. Am. Chem. Soc. 114: 5093-5100, 1992
19. 2. J. Pharmacol. Exp. Ther. 263: 1302-1307, 1992
20. 2, produced by Bacillus cereus BMG302-fF67. I. Taxonomy, production, isolation and preliminary characterization. J. Antibiotics 39: 737-744, 1986
21. 2, produced by Bacillus cereus BMG302-fF67. II. Structure of fatty acid residue and amino acid sequence. J. Antibiotics 39: 745-754, 1986
22. 2, produced by Bacillus cereus BMG302-fF67. III. Structural elucidation of plipastatins. J. Antibiotics 39: 755-761, 1986
23. 2. Structural revision of duramycin and cinnamycin. J. Antibiotics 43: 1403-1412, 1990
24. 2 inhibitors from Ascomycetes. J. Antibiotics 44: 1467-1470, 1991
25. 2 inhibitor, thielocin A1β, and mechanism of action. J. Antibiotics 45: 1071-1078, 1992
26. 2 inhibitors. I. Taxonomy and fermentation of the producing culture; isolation and structures of cinatrins. J. Antibiotics 45: 38-49, 1992
27. 2 inhibitors. II. Biological activities. J. Antibiotics 45: 50-55, 1992
28. 2. Taxonomy, fermentation, isolation, structure determination and biological properties. J. Antibiotics 45: 1195-1201, 1992